Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chloroquine prophylaxis for COVID-19 in high-risk healthcare workers
ACTRN12620000417987Phase 4Terminated
- Sponsor
- Australian Defence Force Malaria and Infectious Disease Institute
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of chloroquine in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Australian Defence Force Malaria and Infectious Disease Institute. Primary endpoint: Number of sick days. Started Apr 2020; status: terminated.
02
Drugs
chloroquine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on ACTRN12620000417987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12620000417987.